Leslie Trigg Sells 65,236 Shares of Outset Medical, Inc. (NASDAQ:OM) Stock

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 65,236 shares of the business’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $0.80, for a total transaction of $52,188.80. Following the completion of the sale, the chief executive officer now directly owns 895,580 shares in the company, valued at $716,464. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Leslie Trigg also recently made the following trade(s):

• On Monday, January 13th, Leslie Trigg sold 33,227 shares of Outset Medical stock. The shares were sold at an average price of $0.81, for a total transaction of $26,913.87.
• On Tuesday, January 7th, Leslie Trigg sold 10,227 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total value of $13,192.83.
• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total value of $4,516.00.

Outset Medical Stock Up 10.3 %

Shares of Outset Medical stock opened at $0.86 on Friday. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. Outset Medical, Inc. has a 52-week low of $0.44 and a 52-week high of $5.22. The company has a market capitalization of $45.18 million, a P/E ratio of -0.31 and a beta of 2.05. The company has a 50 day moving average of $1.01 and a 200 day moving average of $1.28.

Institutional Investors Weigh In On Outset Medical

Institutional investors have recently modified their holdings of the company. Vanguard Personalized Indexing Management LLC acquired a new position in shares of Outset Medical in the 2nd quarter valued at $49,000. National Bank of Canada FI lifted its holdings in shares of Outset Medical by 79.2% in the 3rd quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after purchasing an additional 23,164 shares during the last quarter. Huntington National Bank boosted its position in shares of Outset Medical by 46.2% in the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after purchasing an additional 20,000 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in Outset Medical during the 2nd quarter worth approximately $259,000. Finally, Squarepoint Ops LLC increased its position in Outset Medical by 74.1% during the second quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after buying an additional 34,187 shares during the period.

Analyst Ratings Changes

Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $3.00 price target on shares of Outset Medical in a research note on Tuesday, January 7th.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.